Position in LIVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$462,954
+$104,857 QoQ
Shares Held
5,630
-0.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#177
of 304 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LIVN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $23,257,676 across 12 Medical Devices names. LIVN ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
232,053 | $9,904,022 | |
| 2 | DXCM |
Dexcom Inc
|
55,318 | $3,725,667 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
50,972 | $3,262,717 | |
| 4 | ABT |
Abbott Laboratories
|
27,256 | $2,473,209 | |
| 5 | MDT |
Medtronic plc
|
18,374 | $1,437,398 | |
| 6 | SYK |
Stryker Corp
|
1,823 | $573,953 | |
| 7 | LIVN |
LivaNova PLC
This page
|
5,630 | $462,954 | |
| 8 | PEN |
Penumbra Inc
|
1,301 | $410,790 |
All Filings in LIVN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $462,954 | 5,630 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $358,097 | 5,634 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $316,141 | 5,138 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $325,070 | 6,206 | Shares | Sole | 2025-11-14 | |
| 2022-03-31 | $230,760 | 2,820 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $246,552 | 2,820 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $223,315 | 2,820 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $237,190 | 2,820 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $207,918 | 2,820 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||